Glenmark Life Sciences Ltd.

View in App
830.95 0.00

07 May 2024, 09:07:54 AM
Volume: 308

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glenmarklifesciences.com
Market Cap 10,161.18 Cr.
Enterprise Value(EV) 9,859.58 Cr. 2024-03
Financial Indicators
Earnings per share (EPS) 38.43 Trailing Twelve Months Ending 2024-03
Price-Earning Ratio (PE) 21.58 Trailing Twelve Months Ending 2024-03
Industry PE 42.26 Trailing Twelve Months Ending 2024-03
Book Value / Share 190.35 Trailing Twelve Months Ending 2024-03
Price to Book Value 4.36 Calculated using Price: 829.30
Dividend Yield 2.71 Period Ending 2023-03
No. of Shares Subscribed 12.25 Cr. 122,527,172 Shares
FaceValue 2
About Glenmark Life Sciences Ltd.
The company is in the business of making high-quality drugs by unlocking the possibilities of science.

Glenmark Life Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Glenmark Life Sciences Ltd. Performance

View details >>
1 Day
1 Week
+1.43%
1 Month
+1.67%
3 Month
-6.05%
6 Month
+34.35%
1 Year
+60.62%
2 Year
+81.97%
5 Year
10 Year

Glenmark Life Sciences Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 451.05 127.84 60.91 29.87 22.33
Return on Capital Employed (%) 0 527.74 185.6 96.75 42.24 30.01
Return on Assets (%) -510.59 26.51 19.56 17.82 16.57 15.43

Glenmark Life Sciences Ltd. Balance Sheet

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2024-03* Rs. Cr.
Shh. Funds -1 88 402 753 2,054 2,138 2,332
Non Curr. Liab. 7 16 23 33 60 79
Curr. Liab. 1 1,380 1,307 1,445 747 1,023 439
Minority Int.
Equity & Liab. 0 1,475 1,726 2,221 2,834 3,220 2,850
Non Curr. Assets 545 565 598 706 852 934
Curr. Assets 0 931 1,160 1,623 2,127 2,369 1,916
Misc. Exp. not W/O
Total Assets 0 1,475 1,726 2,221 2,834 3,220 2,850

Glenmark Life Sciences Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2024-03 Rs. Cr. TTM
Net Sales 0 886 1,537 1,885 2,123 2,161 2,283
Other Income 1 12 1 15 29 12
Total Income 0 887 1,549 1,886 2,138 2,190 2,295
Total Expenditure 0 -639 -1,065 -1,294 -1,507 -1,519 -1,609
PBIDT 0 248 484 592 631 671 686
Interest -1 -34 -88 -28 -1 -2
Depreciation -19 -29 -33 -38 -42 -53
Taxation 0 -33 -108 -119 -146 -162 -160
Exceptional Items
PAT 0 196 313 352 419 467 471
Adjusted EPS -8 18 29 33 34 38 38

Glenmark Life Sciences Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 10 195 388 598 313
Cash Fr. Inv. -9 -51 -69 -122 -154
Cash Fr. Finan. 0 1 -137 -214 -79 -388
Net Change 0 2 8 106 397 -228
Cash & Cash Eqvt 0 2 10 116 512 284

Glenmark Life Sciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 82.85 82.85 82.85 82.85 82.85 82.85 82.85 82.85 82.85
Public 17.15 17.15 17.15 17.15 17.15 17.15 17.15 17.15 17.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 9.47 9.47 9.47
No. of Shareholders (in Lacs)

Glenmark Life Sciences Ltd. Announcements

View details >>
Sat, 04 May 2024
Copy of Newspaper Publication
Glenmark Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Fri, 03 May 2024
Shareholders meeting
Glenmark Life Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
Fri, 03 May 2024
Notice Of Shareholders Meetings-XBRL
Glenmark Life Sciences Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

Glenmark Life Sciences Ltd. Technical Scans

View details >>
Mon, 06 May 2024
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Glenmark Life Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 367,026.27 1,535.95 +0.4%
Cipla Ltd. 114,924.60 1,423.40 0.0%
Divi's Laboratories Ltd. 105,128.21 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. 105,108.85 6,329.90 +0.6%
Zydus Lifesciences Ltd. 102,736.49 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. 91,906.55 2,723.30 +0.2%
Mankind Pharma Ltd. 91,490.39 2,270.00 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.21 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-12 30.99 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 76.02 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.10 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.55 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.52 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-12 52.97 2,270.00 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.88 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-12 4.44 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 8.07 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.91 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.45 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.85 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.30 2,270.00 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,270.00 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,270.00 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,270.00 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,270.00 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,535.95 +0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,423.40 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,969.55 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,329.90 +0.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,029.00 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,723.30 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,270.00 -0.7%

Glenmark Life Sciences Ltd. FAQ's

What is Glenmark Life Scienc share price?
Can I buy Glenmark Life Scienc shares now?
What is the Dividend Yield of Glenmark Life Scienc?
What is the Market Cap of Glenmark Life Scienc?
What are the key metrics to analyse Glenmark Life Scienc?
What is the 52 Week High and Low of Glenmark Life Scienc?
What is the trend of Glenmark Life Scienc share price?